Perrigo Company plc Current Federal Tax Expense (Benefit)
Perrigo Company plc (PRGO) reported Current Federal Tax Expense (Benefit) of $11.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-26
- Perrigo Company plc current federal tax expense (benefit) for fiscal 2025 was $11.20M, a 386.96% increase from fiscal 2024.
- Perrigo Company plc current federal tax expense (benefit) for fiscal 2024 was $2.30M, a 15.00% increase from fiscal 2023.
- Perrigo Company plc current federal tax expense (benefit) for fiscal 2023 was $2.00M, a 28.57% decline from fiscal 2022.
- Perrigo Company plc current federal tax expense (benefit) for fiscal 2022 was $2.80M, a 99.08% decline from fiscal 2021.
| Period end | Current Federal Tax Expense (Benefit) 6 month | Current Federal Tax Expense (Benefit) 6 month as first filed | Current Federal Tax Expense (Benefit) 12 month | Current Federal Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $11.20M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $2.30M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $2.00M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $2.80M 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $303.60M 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $100.00K 10-K · filed 2023-02-28 | $2.70M 10-K · filed 2021-03-01 | ||
| 2019-12-31 | -$500.00K 10-K · filed 2022-03-01 | -$2.20M 10-K · filed 2020-02-27 | ||
| 2018-12-31 | $22.70M 10-K · filed 2021-03-01 | |||
| 2017-12-31 | -$8.10M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $300.00K 10-K · filed 2019-02-27 | $93.00M 10-K · filed 2017-05-22 | ||
| 2015-12-31 | $1.60M 10-K · filed 2018-03-01 | $59.20M 10-KT · filed 2016-02-25 | ||
| 2015-06-27 | -$2.20M 10-K · filed 2018-03-01 | $77.00M 10-K · filed 2015-08-13 | ||
| 2014-06-28 | $42.80M 10-K · filed 2017-05-22 | $44.00M 10-K · filed 2014-08-14 | ||
| 2013-06-29 | $125.00M 10-KT · filed 2016-02-25 | |||
| 2012-06-30 | $74.90M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |